Study of IBI3020 Treatment in Participants With Late-Stage Solid Tumors
Study of IBI3020 Treatment in Participants With Late-Stage Solid Tumors
Recruiting · NCT06963281 · Registry updated 2026-09-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of IBI3020 Treatment in Participants With Late-Stage Solid Tumors | Solid Tumors | Recruiting | Phase 1 | 2026-09-25 | NCT06963281 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Fortvita Biologics (USA)Inc. | 7 |
| Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD. | 8 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Mayo Clinic - Arizona | Phoenix | United States | 9 |
| Mayo Clinic - Florida | Jacksonville | United States | 14 |
| Mayo Clinic - Rochester | Rochester | United States | 59 |
| Montefiore Cancer Center | New York | United States | 1 |
| NEXT Dallas | Irving | United States | 18 |
| NEXT Houston | Houston | United States | 11 |
| Shandong Cancer Hospital | Jinan | China | 1 |
| Shanxi Cancer Hospital | Taiyuan | China | 1 |
| The sixth affiliated hospital, Sun Yat-sen University | Guangzhou | China | 1 |